Global Epidemiology Forecast for Diabetic Peripheral Neuropathy to 2030

到2030年糖尿病周围神经病变的全球流行病学预测

2020-02-14 08:20:17 CISION

本文共2010个字,阅读需6分钟

The "Diabetic Peripheral Neuropathy - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology trends of Diabetic Peripheral Neuropathy in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.Diabetic Peripheral Neuropathy Report Assessment Key Benefits Diabetic Peripheral Neuropathy - Disease UnderstandingDiabetic peripheral neuropathy (DPN) also known distal symmetric polyneuropathy (DSPN) is defined as the symptoms and/or signs of peripheral nerve dysfunction and nerve damage in diabetic patients after the exclusion of other causes. It is a predominantly sensory neuropathy with autonomic nervous system involvement, although there are often motor features with advancing disease.Diabetic Peripheral Neuropathy - EpidemiologyThe Diabetic Peripheral Neuropathy epidemiology division provide insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Diagnosed Prevalence of Diabetic Peripheral Neuropathy in 7MM, Gender-Specific Prevalence of Diabetic Peripheral Neuropathy in 7MM, Total Diagnosed Prevalence of Painful Diabetic Peripheral Neuropathy in 7MM), scenario of Total Diagnosed Prevalence of Diabetic Peripheral Neuropathy in 7MM in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2030.The publisher's estimations suggests the total prevalent cases of Diabetic Peripheral Neuropathy in the 7MM was found to be approximately 25,332,829 in 2017. Among 7MM, United States has the prevalent population of Diabetic Peripheral Neuropathy with about 12,522,483 cases in 2017. Among EU-5 countries, Germany has the highest prevalent cases with 3,904,730 cases, followed by Italy with 1,636,426 cases in 2017. However, Spain has the least number of diagnosed prevalent cases.In 2017, the prevalent population of Diabetic Peripheral Neuropathy in Japan was found to be approximately 2,332 cases.Key Topics Covered: 1. Key Insights2. Executive summary3. Diabetic Peripheral Neuropathy (DPN): Patient Overview at a Glance3.1. Total Patient Share (%) Distribution of DPN in 20173.2. Total Patient Share (%) Distribution of DPN in 20304. Epidemiology Methodology5. Disease Background and Overview: Diabetic Peripheral Neuropathy (DPN)5.1. Introduction5.2. Classification of Diabetic Neuropathies5.3. Signs and Symptoms5.4. Risk Factors5.5. Pathogenesis5.6. Diagnosis5.7. Recent developments in early diagnosis of DPN with POCDs5.8. Differential Diagnosis6. Epidemiology and Patient Population: Diabetic Peripheral Neuropathy (DPN)6.1. Key Findings6.2. Total Diagnosed Prevalent cases of Diabetic Peripheral Neuropathy (DPN) in 7MM6.3. United States6.3.1. Assumptions and Rationale6.3.2. Total Diagnosed Prevalent Cases of Diabetic Peripheral Neuropathy in the United States6.3.3. Gender-Specific Cases of Diabetic Peripheral Neuropathy in the United States6.3.4. Total Prevalent Cases of Painful Diabetic Peripheral Neuropathy in the United States6.4. EU56.4.1. Assumptions and Rationale6.5. Germany6.5.1. Total Diagnosed Prevalent Cases of Diabetic Peripheral Neuropathy in Germany6.5.2. Gender-Specific Cases of Diabetic Peripheral Neuropathy in Germany6.5.3. Total Prevalent Cases of Painful Diabetic Peripheral Neuropathy in Germany6.6. France6.6.1. Total Diagnosed Prevalent Cases of Diabetic Peripheral Neuropathy in France6.6.2. Gender-Specific Cases of Diabetic Peripheral Neuropathy in France6.6.3. Total Prevalent Cases of Painful Diabetic Peripheral Neuropathy in France6.7. Italy6.7.1. Total Diagnosed Prevalent Cases of Diabetic Peripheral Neuropathy in Italy6.7.2. Gender-Specific Cases of Diabetic Peripheral Neuropathy in Italy6.7.3. Total Prevalent Cases of Painful Diabetic Peripheral Neuropathy in Italy6.8. Spain6.8.1. Total Diagnosed Prevalent Cases of Diabetic Peripheral Neuropathy in Spain6.8.2. Gender-Specific Cases of Diabetic Peripheral Neuropathy in Spain6.8.3. Total Prevalent Cases of Painful Diabetic Peripheral Neuropathy in Spain6.9. United Kingdom (UK)6.9.1. Total Diagnosed Prevalent Cases of Diabetic Peripheral Neuropathy in the UK6.9.2. Gender-Specific Cases of Diabetic Peripheral Neuropathy in the UK6.9.3. Total Prevalent Cases of Painful Diabetic Peripheral Neuropathy in the UK6.10. Japan6.10.1. Assumptions and Rationale6.10.2. Total Diagnosed Prevalent Cases of Diabetic Peripheral Neuropathy in Japan6.10.3. Gender-Specific Cases of Diabetic Peripheral Neuropathy in Japan6.10.4. Total Prevalent Cases of Painful Diabetic Peripheral Neuropathy in Japan7. Treatment and Management of DPN7.1. Guidelines for the management of DPN8. Unmet need9. Bibliography10. Appendix11. Report MethodologyFor more information about this report visit https://www.researchandmarkets.com/r/qkor1s Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
“糖尿病周围神经病变-流行病学预测-2030”报告已添加到市场研究。com 的产品。 本报告深入了解美国、 EU5(德国、西班牙、意大利、法国和英国)和日本糖尿病周围神经病变的疾病、历史和预测流行病学趋势。糖尿病周围神经病变报告评估 主要好处 糖尿病周围神经病变-疾病了解糖尿病周围神经病变( DPN )又称远端对称多神经病( DSP N ),是指糖尿病患者排除其他原因后出现的周围神经功能障碍和神经损害的症状和/或体征。它是一种主要的感觉神经病变与自主神经系统参与,虽然往往有运动特点与进展性疾病。糖尿病周围神经病变-流行病学糖尿病周围神经病变流行病学部门提供关于每7个主要国家的历史和当前的病人池和预测趋势的见解。它有助于通过探索许多重要意见领袖的研究和观点来认识当前和预测趋势的原因。报告的这一部分还提供了诊断患者的情况和他们的趋势以及所做的假设。该报告所涵盖的疾病流行病学资料提供了历史和预测流行病学资料(7MM 糖尿病周围神经病变的总诊断患病率、7MM 糖尿病周围神经病变的性别特异性患病率、7MM 糖尿病周围神经病变的总诊断患病率),2017-2030年7MM 中糖尿病周围神经病变在美国、欧盟5国(德国、西班牙、意大利、法国和英国)和日本的诊断总患病率。发行人的估算显示,2017年7MM 中糖尿病周围神经病变的总流行病例被发现约为25,332,829例。在7MM 中,美国有糖尿病周围神经病变的流行人群,2017年约12,522,483例。在欧盟5国中,德国发病率最高,为3904730例,其次是意大利,2017年为1636426例。然而,西班牙确诊的流行病例最少。2017年,日本糖尿病周围神经病变流行人群约2332例。所涵盖的主要专题:1。关键见解2。执行首脑会议3。糖尿病周围神经病变( DPN ):患者概览3.1。总患者份额(%)分布 DPN 在20173.2。2034年 DPN 总患者份额(%)分布情况。流行病学方法。疾病背景与概述:糖尿病周围神经病变( DPN )5.1。导言。糖尿病神经病变的分类。症状和体征。风险因素5.5。发病5.6。诊断5.7。POCDs5.8早期诊断 DPN 的最新进展.鉴别诊断6。流行病学与患者人群:糖尿病周围神经病变( DPN )6.1。关键发现6.2。7MM6.3糖尿病周围神经病变( DPN )预诊断总病例。美国。1。假设和理由6.3。2。美国糖尿病周围神经病变预诊断总病例6.3。3。美国糖尿病周围神经病变性别特异性病例6.3。4。美国糖尿病周围神经病变的总预后病例6.4。EU56.4。1。假设和理由6.5。德国6.5。1。德国糖尿病周围神经病变预诊断总病例6.5。2。德国糖尿病周围神经病变性别特异性病例6.5。3。德国糖尿病周围神经病变的总预后病例6.6。France6.6。1。弗朗西6.6糖尿病性周围神经病变的诊断预后病例总数。2。弗朗西6.6糖尿病周围神经病变的性别特异性病例.3。方济各6.7例糖尿病周围神经病变的总预后病例。Italy6.7。1。糖尿病性周围神经病变预诊断总病例6.7。2。糖尿病周围神经病变性别特异性病例6.7。3。糖尿病性糖尿病性周围神经病变总预后6.8例。西班牙6.8。1。Spain 6.8糖尿病性周围神经病变的诊断预后病例总数。2。Spain 6.8糖尿病周围神经病变性别特异性病例.3。腹痛糖尿病周围神经病变6.9例临床分析.联合王国(联合王国)6.9。1。UK6.9糖尿病周围神经病变预诊断总病例.2。UK6.9糖尿病周围神经病变性别特异性病例.3。UK6.10糖尿病周围神经病变的总预后病例.日本6.10.1。假设及理由6.10.2。日本糖尿病周围神经病变预诊断总病例6.10.3。日本糖尿病周围神经病变性别特异性病例6.10.4。日本糖尿病周围神经病变的总预后病例7。DPN7.1的处理和管理。DPN8管理指南。未满足的需要。参考书目。附录11。报告方法有关此报告的详细信息,请访问 https://www.research andmarkets.com/r/qkor1 研究和市场还提供定制研究服务,提供重点,全面和定制的研究。 媒体联系人: 研究与市场 Laura Wood ,高级经理 press @ research and markets.com for E.S.T Office Hours Call +1-917-300-0470 for U.S ./ CAN 免费 Call +1-800-526-8630适用于 GMT Office Hours Call +353-1-416-8900 U.S.Fax :646-607-1907传真(外部号码:+353-1-481-1716 SOURCE 研究与市场 相关链接 http://www.research and markets.com

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文